Music may soothe hospital confusion for Alzheimer's and Parkinson's patients

NCT ID NCT07137949

Recruiting now Symptom relief Sponsor: Boston Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a personalized music therapy program to prevent delirium (sudden confusion) in hospitalized people with neurodegenerative diseases like Alzheimer's or Parkinson's. Thirty participants will receive up to five live music sessions tailored to their preferences. Researchers will measure how feasible the therapy is and whether it reduces delirium symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: music therapy
What this could lead to: If it works, this could point toward a simple, drug-free way to reduce confusion and improve hospital stays for people with brain diseases.
What could go wrong: This is a very small pilot study (30 people) with no comparison group, so results may not be generalizable. The therapy may not prevent delirium or may be hard to deliver consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Lewy body dementia Parkinson disease vascular dementia delirium prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELIRIUM

Contacts and locations

Locations

Boston Medical Center
RECRUITING

Boston, Massachusetts, 02118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.